At least for Her2, the new information reported in this study on matriptase cleavage and the interactions of the CTFs with the monoclonal antibody cancer drug Herceptin may have a practical application beyond our initial intent of testing for test tube substrate cleavages in the cellular membrane-associated context. The gene discussed is ERBB2; the disease is cancer.